Two faces of oesophageal cancer – epidemiology and etiology

Czech version

Authors: S. Magnusková ¹; H. Kollárová ¹; V. Kamarád ²; K. Azeem ¹
Authors‘ workplace: Ústav preventivního lékařství, LF UP v Olomouci ¹; Ústav histologie a embryologie, LF OU v Ostravě ²
Published in: Gastroent Hepatol 2011; 65(5): 255-263
Category: Clinical and Experimental Gastroenterology: Review Article

Overview

Oesophageal cancer is the eighth most common form of cancer worldwide. The past 30 years have seen significant changes in the epidemiology of the two major histological types of oesophageal cancer – squamous cell carcinoma and adenocarcinoma. This paper aims to summarise the two types of esophageal cancer in terms of epidemiology and etiology. PubMed, Web of Science and selected specialist Czech and foreign literature were searched for the most recent findings on the etiology and risk factors of oesophagus. GLOBOCAN 2008 and the web portal of epidemiology of malignant tumours (SVOD) served as sources of epidemiological data such as incidence, mortality and survival rates. The highest incidence of oesophageal squamous cell carcinoma is in developing countries. While the incidence and prevalence of oesophageal squamous cell carcinoma remains about the same, a significant increase in oesophageal adenocarcinoma can be seen in Western countries. The etiology of oesophageal cancer is multifactorial. Excessive alcohol consumption and smoking are major risk factors in oesophageal squamous cell carcinoma. Atrophy of the gastric mucosa, consumption of hot food or pickled vegetables, and low socioeconomic levels also increase the risk of oesophageal squamous cell carcinoma. Groups at risk of oesophageal adenocarcinoma include males, whites, those with oesophageal reflux disease and those who are obese or have Barrett’s oesophagus. On the other hand, sufficient consumption of fruit and vegetables and the use of nonsteroidal anti-inflammatory drugs, including aspirin, have been confirmed as protective factors for both histological types. In view of the fact that the incidence of oesophageal cancer in the Czech Republic is on the increase, knowledge of its risk, as well as protective factors, is important for the success of preventive measures. A change in eating habits and reduced consumption of alcohol and smoking can significantly lessen the incidence of and mortality from oesophageal squamous cell carcinoma. Regarding oesophageal adenocarcinoma, attention should be also paid to gastrooesophageal reflux disease, achalasia and its precancerosis, Barrett‘s oesophagus. Changes in lifestyle, such as weight loss, are further ways in which the incidence of oesophageal adenocarcinoma might be reduced. An important role is also played by education against smoking or, in patients with gastrooesophageal reflux disease, antireflux therapy.

Key words:
oesophageal adenocarcinoma – Barrett‘s oesophagus – epidemiology – etiology – oesophageal squamous cell carcinoma

Sources

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893–2917.

2. Coleman MP, Gatta G, Verdecchia A et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003; 14 (Suppl 5): 128–149.

3. Lambert R, Hainaut P. Epidemiology of oesophagogastric cancer. Baillieres Best Pract Res Clin Gastroenterol 2007; 21(6): 921–945.

4. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24(5): 729–735.

5. Dušek L et al. Epidemiology of malignant tumours of the oesophagus (C15). In: Czech cancer care in numbers 2008–2009. Praha: Grada 2010: 112.

6. Klener P. Karcinom jícnu. In: Klinická onkologie. Praha: Karolinum-Galén 2002: 397–398.

7. Dušek L et al. Český národní webový portál epidemiologie nádorů (online). Masarykova Univerzita 2005 [cited 2011 26.04.]; Available from: http://www.svod.cz.

8. Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer 2003; 105(1): 98–100.

9. Hashibe M, Boffetta P, Janout V et al. Esophageal cancer in Central and Eastern Europe: tobacco and alcohol. Int J Cancer 2007: 120(7): 1518–1522.

10. Koop CE, Luoto J. „The Health Consequences of Smoking: Cancer,“ overview of a report of the Surgeon General. Public Health Rep 1982; 97(4): 318–324.

11. Lee CH, Lee JM, Wu DC et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 2005; 113(3): 475–482.

12. Jankowski JA, Wright NA, Meltzer SJ et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154(4): 965–973.

13. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004; 85: 1–334.

14. Nasrollahzadeh D, Kamangar F, Aghcheli K et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008; 98(11): 1857–1863.

15. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. IARC Alcoholic Beverage Consumption and Ethyl Carbamate (Urethane). IARC Monogr Eval Carcinog Risks Hum 2007; 96.

16. Brown LM, Hoover R, Silverman D et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001; 153(2): 114–122.

17. Freedman ND, Abnet CC, Leitzmann MF et al. A prospective study of tobacco, alcohol, and the risk of oesophageal and gastric cancer subtypes. Am J Epidemiol 2007; 165(12): 1424–1433.

18. Bosetti C, La Vecchia C, Negri E et al. Wine and other types of alcoholic beverages and the risk of esophageal cancer. Eur J Clin Nutr 2000; 54(12): 918–920.

19. Castellsague X, Munoz N, De Stefani E et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 1999; 82(5): 657–664.

20. Bosetti C, Franceschi S, Levi F et al. Smoking and drinking cessation and the risk of oesophageal cancer. Br J Cancer 2000; 83(5): 689–691.

21. Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12(8): 721–732.

22. Kollarova H, Machova L, Horakova D et al. Risk of oesophageal cancer. Ces a Slov Gastroent a Hepatol 2008; 62(2): 79–83.

23. De Jong UW, Day NE, Mounier-Kuhn PL et al. The relationship between the ingestion of hot coffee and intraoesophageal temperature. Gut 1972; 13(1): 24–30.

24. Castellsague X, Munoz N, De Stefani E et al. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int J Cancer 2000; 88(4): 658–664.

25. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Overall Evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42, Supplement 7. IARC Monogr Eval Carcinog Risks Hum; 1987.

26. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Monogr Eval Carcinog Risks Hum 1991; 51: 1–513.

27. Sewram V, De Stefani E, Brennan P et al. Mate consumption and the risk of squamous cell esophageal cancer in Uruguay. Cancer Epidemiol Biomarkers Prev 2003; 12(6): 508–513.

28. Kamangar F, Schantz MM, Abnet CC et al. High levels of carcinogenic polycyclic aromatic hydrocarbons in mate drinks. Cancer Epidemiol Biomarkers Prev 2008; 17(5): 1262–1268.

29. Yang CS. Research on esophageal cancer in China: a review. Cancer Res 1980; 40(8 Pt 1): 2633–2644.

30. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans Pickled vegetables. IARC Monogr Eval Carcinog Risks Hum 1993; 56: 83–113.

31. Islami F, Ren JS, Taylor PR et al. Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Br J Cancer 2009; 101(9): 1641–1647.

32. Tran GD, Sun XD, Abnet CC et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113(3): 456–463.

33. Islami F, Sheikhattari P, Ren JS et al. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma – a systematic review and meta-analysis. Ann Oncol 2011; 22(4): 754–760.

34. Ye W, Held M, Lagergren J et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004; 96(5): 388–396.

35. Ruder AM, Ward EM, Brown DP. Mortality in dry-cleaning workers: an update. Am J Ind Med 2001; 39(2): 121–132.

36. Parent ME, Siemiatycki J, Fritschi L. Workplace exposures and oesophageal cancer. Occup Environ Med 2000; 57(5): 325–334.

37. Straif K, Weiland SK, Bungers M et al. Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers. Occup Environ Med 2000; 57(3): 180–187.

38. Micke O, Schafer U, Glashorster M et al. Radiation-induced esophageal carcinoma 30 years after mediastinal irradiation: case report and review of the literature. Jpn J Clin Oncol 1999; 29(3): 164–170.

39. Marchese MJ, Liskow A, Chang CH. Radiation therapy associated cancer of the esophagus. N Y State J Med 1986; 86(3): 152–153.

40. Kirova YM, Asselain B, Fourquet A. Can we consider always an esophageal carcinoma as radiation associated cancer after irradiation for breast cancer? Am J Clin Oncol 2009; 32(2): 197–199.

41. Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63(4): 570–580.

42. Lukanich JM. Section I: epidemiological review. Semin Thorac Cardiovasc Surg 2003; 15(2): 158–166.

43. Thomas T, Abrams KR, De Caestecker JS et al. Meta analysis: Cancer risk in Barrett‘s oesophagus. Aliment Pharmacol Ther 2007; 26(11–12): 1465–1477.

44. Lukáš K. Barrettův jícen z pohledu gastroenterologa. Novinky z gastroenterologie 2000; 1: 3–6.

45. Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340(11): 825–831.

46. Chak A, Faulx A, Eng C et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer 2006; 107(9): 2160–2166.

47. Spechler SJ, Fitzgerald RC, Prasad GA et al. History, molecular mechanisms, and endoscopic treatment of Barrett‘s esophagus. Gastroenterology 2010; 138(3): 854–869.

48. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143(3): 199–211.

49. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15(5): 872–878.

50. Cook MB, Greenwood DC, Hardie LJ et al. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett‘s esophagus. Am J Gastroenterol 2008; 103(2): 292–300.

51. Chow WH, Blaser MJ, Blot WJ et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58(4): 588–590.

52. Lukáš K. Vztah infekce Helicobacter pylori a refluxní choroby jícnu. Interní medicína pro praxi 2006; 2: 76–78.

53. Whiteman DC, Parmar P, Fahey P et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010; 139(1): 73–83.

54. Rokkas T, Pistiolas D, Sechopoulos P et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007; 5(12): 1413–1417.

55. Whiteman DC, Sadeghi S, Pandeya N et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57(2): 173–180.

56. Lukáš K. Je hiátová hernie synonynem pro refluxní chorobu jícnu? Čes a Slov Gastroent a Hepatol 2004; 58(3): 110–115.

57. Kamangar F, Chow WH, Abnet CC et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009; 38(1): 27–57.

58. Veugelers PJ, Porter GA, Guernsey DL et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006; 19(5): 321–328.

59. Chen Z, Yang G, Zhou M et al. Body mass index and mortality from ischaemic heart disease in a lean population: 10 year prospective study of 220,000 adult men. Int J Epidemiol 2006; 35(1): 141–150.

60. Gammon MD, Schoenberg JB, Ahsan H et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89(17): 1277–1284.

61. Jansson C, Johansson AL, Bergdahl IA et al. Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers. Cancer Causes Control 2005; 16(6): 755–764.

62. Engel LS, Vaughan TL, Gammon MD et al. Occupation and risk of esophageal and gastric cardia adenocarcinoma. Am J Ind Med 2002; 42(1): 11–22.

63. Jansson C, Jeding K, and Lagergren J. Job strain and risk of esophageal and cardia cancers. Cancer Epidemiol 2009; 33(6): 473–475.

64. Guo W, Blot WJ, Li JY et al. A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol 1994; 23(3): 444–450.

65. Gonzalez CA, Pera G, Agudo A et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006; 118(10): 2559–2566.

66. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research//World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 1999; 15(6): 523–526.

67. Nutritional aspects of the development of cancer. Report of the Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy. Rep Health Soc Subj (Lond) 1998; 48:i-xiv: 1–274.

68. Sapkota A, Hsu CC, Zaridze D et al. Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control 2008; 19(10): 1161–1170.

69. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78 (3 Suppl): 559S–569S.

70. Thompson OM, Beresford SA, Kirk EA et al. Vegetable and fruit intakes and risk of Barrett‘s esophagus in men and women. Am J Clin Nutr 2009; 89(3): 890–896.

71. Leeuwenburgh I, Haringsma J, Van Dekken H et al. Long-term risk of oesophagitis, Barrett‘s oesophagus and oesophageal cancer in achalasia patients. Scand J Gastroenterol Suppl 2006; (243): 7–10.

72. Zendehdel K, Nyren O, Edberg A et al. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in sweden. Am J Gastroenterol 2011; 106(1): 57–61.

73. Corley DA, Kerlikowske K, Verma R et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003; 124(1): 47–56.

74. Rothwell PM, Wilson M, Elwin CE et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376(9754): 1741–1750.

75. Dillner J, Knekt P, Schiller JT et al. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Bmj 1995; 311(7016): 1346.

76. Bjorge T, Hakulinen T, Engeland A et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57(18): 3989–3992.

77. Han C, Qiao G, Hubbert NL et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J Natl Cancer Inst 1996; 88(20): 1467–1471.

78. Kamangar F, Qiao YL, Schiller JT et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer 2006; 119(3): 579–584.

79. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90: 1–636.

80. Smith M, Zhou M, Whitlock G et al. Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 2008; 122(7): 1604–1610.

81. Brown LM, Devesa SS. Epidemiology and risk of esophageal cancer: clinical. In: Jobe BA, Thomas C, Hunter JG. Esophageal Cancer: Principles and Practice. New York: Demos Medical Publishing 2009: 103–113.

82. Zavoral M. Epidemiologie, screening, současná diagnostika a staging karcinomu jícnu. Bulletin HPB chirurgie 2008; 16(1–2): 9–10.

83. de Jonge PJ, Steyerberg EW, Kuipers EJ et al. Risk factors for the development of esophageal adenocarcinoma in Barrett‘s esophagus. Am J Gastroenterol 2006; 101(7): 1421–1429.